1. Academic Validation
  2. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations

Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations

  • Bioorg Med Chem. 2011 Jan 15;19(2):735-43. doi: 10.1016/j.bmc.2010.12.030.
Varnavas D Mouchlis 1 Victoria Magrioti Efrosini Barbayianni Nathan Cermak Rob C Oslund Thomas M Mavromoustakos Michael H Gelb George Kokotos
Affiliations

Affiliation

  • 1 Department of Chemistry, University of Athens, Greece.
Abstract

Group IIA secreted Phospholipase A₂ (GIIA sPLA₂) is a member of the mammalian sPLA₂ enzyme family and is associated with various inflammatory conditions. In this study, the synthesis of 2-oxoamides based on α-amino acids and the in vitro evaluation against three secreted sPLA₂s (GIIA, GV and GX) are described. The long chain 2-oxoamide GK126 based on the amino acid (S)-leucine displayed inhibition of human and mouse GIIA sPLA₂s (IC₅₀ 300nM and 180nM, respectively). It also inhibited human GV sPLA₂ with similar potency, while it did not inhibit human GX sPLA₂. The elucidation of the stereoelectronic characteristics that affect the in vitro activity of these compounds was achieved by using a combination of simulated annealing to sample low-energy conformations before the docking procedure, and molecular docking calculations.

Figures
Products